Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma XXXX : a single-centre experience.

@entity5 @entity1 @entity3
BACKGROUND: The aim of the present study was to analyse the outcome after hepatic resection for non-colorectal, non-neuroendocrine, non-sarcomatous (NCNNNS) @entity5 and to identify the factors predicting survival. METHODS: All @entity1 who underwent hepatic resection for NCNNNS @entity5 between September 1996 and June 2009 were included. @entity1 ' demographics, clinical and histopathological parameters, overall survival and the factors predicting survival were analysed. RESULTS: In all, 65 @entity1 underwent hepatic resection for @entity3 . The most common site of a primary @entity5 was the kidney (24 @entity1 ). Fifteen @entity1 had @entity5 . Fifty @entity1 had major liver resections and 22 @entity1 had bilobar disease. The median number of liver lesions resected was 1 and the median maximum diameter of the @entity3 was 6 cm. A R0 resection was performed in 51 @entity1 . The 1-, 3- and 5-year overall survival from the time of metastasectomy was 72.9%, 47.9% and 25.6%, respectively, with a median survival of 19 months. The presence of a @entity5 of greater than 6 cm (P= 0.048) and a positive resection margin (P= 0.04) were associated with poor survival. CONCLUSION: Hepatic resection for @entity3 from NCNNNS @entity5 can offer acceptable long-term survival in selected @entity1 . To offer a chance of a cure a R0 resection must be performed.
